Trump sends New York Times reporter handwritten note saying he's 'very proud' of COVID vaccines
After former President Donald Trump disclosed to a booing crowd Sunday that he had received a COVID-19 booster shot, New York Times reporter Maggie Haberman "asked a Trump spokeswoman why he switched his message on the vaccine/booster" — Trump suggested in September that he would not get boosted — and Trump himself wrote back, saying he is "very proud to have produced the three vaccines so quickly," Haberman tweeted Monday evening. On request, she posted an image of the handwritten note.
The Trump administration facilitated the rapid rollout of the Pfizer, Moderna, and Johnson & Johnson vaccines through a financial infusion and purchase guarantee program called Operation Warp Speed, though the mRNA technology used in the Pfizer and Moderna vaccines had been decades in development. Trump did not announce that he had quietly gotten vaccinated in his last days in office until at least weeks after he left the White House.
Trump supporters are among the largest group of unvaccinated Americans, and on the occasions Trump encourages them to get inoculated, his fans aren't generally receptive to the idea. Watch one Trump voter tell The Daily Show's Jordan Klepper she won't get vaccinated in part because she feels the vaccines were developed too quickly — or, as Klepper prompts her, at "warp speed."
The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Peter has worked as a news and culture writer and editor at The Week since the site's launch in 2008. He covers politics, world affairs, religion and cultural currents. His journalism career began as a copy editor at a financial newswire and has included editorial positions at The New York Times Magazine, Facts on File, and Oregon State University.
-
How to financially prepare for divorceThe Explainer Facing ‘irreconcilable differences’ does not have to be financially devastating
-
Why it’s important to shop around for a mortgage and what to look forThe Explainer You can save big by comparing different mortgage offers
-
4 ways to save on rising health care costsThe Explainer Health care expenses are part of an overall increase in the cost of living for Americans
-
A fentanyl vaccine may be on the horizonUnder the radar Taking a serious jab at the opioid epidemic
-
Health: Will Kennedy dismantle U.S. immunization policy?Feature ‘America’s vaccine playbook is being rewritten by people who don’t believe in them’
-
How dangerous is the ‘K’ strain super-flu?The Explainer Surge in cases of new variant H3N2 flu in UK and around the world
-
The stalled fight against HIVThe Explainer Scientific advances offer hopes of a cure but ‘devastating’ foreign aid cuts leave countries battling Aids without funds
-
Vaccine critic quietly named CDC’s No. 2 officialSpeed Read Dr. Ralph Abraham joins another prominent vaccine critic, HHS Secretary Robert F. Kennedy Jr.
-
This flu season could be worse than usualIn the spotlight A new subvariant is infecting several countries
-
Obesity drugs: Will Trump’s plan lower costs?Feature Even $149 a month, the advertised price for a starting dose of a still-in-development GLP-1 pill on TrumpRx, will be too big a burden for the many Americans ‘struggling to afford groceries’
-
Can TrumpRx really lower drug prices?Today’s Big Question Pfizer’s deal with Trump sent drugmaker stocks higher
